在传染病的化疗中重新利用药物
Amal Hamid1, Pascal Mäser2,3, Abdelhalim Babiker Mahmoud1,4,5
1Faculty of Pharmacy, University of Khartoum, Khartoum 11111, Sudan.
Molecules (Basel, Switzerland)
|February 10, 2024
概括
药物再利用提供了一个高效的创新途径,特别是在传染病方面. 该策略涉及使用现有药物用于新的治疗点,与新药开发相比节省时间和成本.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 药物再利用是一种具有成本效益的创新策略,对于开发新疗法至关重要.
- COVID-19大流行加速了药物重新定位的努力,揭示了机遇和挑战.
- 开发新药是一个漫长而昂贵的过程,往往超过十年和10亿美元.
研究的目的:
- 分析药物重用在传染病中的优缺点.
- 为了分类和探索不同的药物重用方法.
- 提供成功的药物重用在抗感染化疗中的例子.
主要方法:
- 区分机会主义 (选批准的化合物) 和理性 (基于目标的) 重新利用方法.
- 将理性重新利用分为分歧 (共享祖先目标) 和融合 (共享生活方式目标) 的战略.
- 用抗感染性化疗的案例研究说明重用场景.
主要成果:
- 机会主义的重新用途通过利用现有的药物批准来节省时间和金钱.
- 理性重新定位针对病原体的保存机制,提供更广泛的适用性.
- 不同和融合的理性方法利用病原体之间的进化和功能相似性.
结论:
- 药物重新定位是传染病治疗的重要策略,与新开发相比,它提供了显著的优势.
- 了解不同的重新定位方法 (机会主义,理性,分歧,融合) 是最大化成功的关键.
- 案例研究表明,重定向药物在有效打击传染病方面的潜力.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
291
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
291
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


